Vanguard Portfolio Management »

United Therapeutics Corporation shares owned by Vanguard Portfolio Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Vanguard Portfolio Management from 13F filings

Historical chart of Vanguard Portfolio Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Vanguard Portfolio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2B 2.0M 592.98

More positions owned by Vanguard Portfolio Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Vanguard Portfolio Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Renaissance Technologies
State Street Corporation
Geode Capital Management
Henderson Group
AQR Capital Management
Citadel Advisors
Assetmark
Invesco
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation